Cited by 435Alzheimer's disease research and treatmentsNF-κB Signaling PathwaysNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease

Open access

Chen, Chia-Hsiung, Zhou, Weihui, Liu, Shengchun, Deng, Yu, Cai, Fang, Tone, Masahide, Tone, Yukiko, Tong, Yigang, Song, Weihong·2012·The International Journal of Neuropsychopharmacology

DOI 10.1017/s1461145711000149

Open this paper in CoChat — free account Open PDF

Abstract

Elevated levels of β-site APP cleaving enzyme 1 (BACE1) were found in the brain of some sporadic Alzheimer's disease (AD) patients; however, the underlying mechanism is unknown. BACE1 cleaves β-amyloid precursor protein (APP) to generate amyloid β protein (Aβ), a central component of neuritic plaques in AD brains. Nuclear factor-kappa B (NF-κB) signalling plays an important role in gene regulation and is implicated in inflammation, oxidative stress and apoptosis. In this report we found that both BACE1 and NF-κB p65 levels were significantly increased in the brains of AD patients. Two functional NF-κB-binding elements were identified in the human BACE1 promoter region. We found that NF-κB p65 expression resulted in increased BACE1 promoter activity and BACE1 transcription, while disruption of NF-κB p65 decreased BACE1 gene expression in p65 knockout (RelA-knockout) cells. In addition, NF-κB p65 expression leads to up-regulated β-secretase cleavage and Aβ production, while non-steroidal anti-inflammatory drugs (NSAIDs) inhibited BACE1 transcriptional activation induced by strong NF-κB activator tumour necrosis factor-alpha (TNF-α). Taken together, our results clearly demonstrate that NF-κB signalling facilitates BACE1 gene expression and APP processing, and increased BACE1 expression mediated by NF-κB signalling in the brain could be one of the novel molecular mechanisms underlying the development of AD in some sporadic cases. Furthermore, NSAIDs could block the inflammation-induced BACE1 transcription and Aβ production. Our study suggests that inhibition of NF-κB-mediated BACE1 expression may be a valuable drug target for AD therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1017/s1461145711000149

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 5,882
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.
Schreck, R., RIEBER, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,793
Structure, Regulation and Function of NF-kappaB
Siebenlist, U. K., Franzoso, G., & Brown, K. D. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,086
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Nuclear Factor Kb: An Oxidative Stress-Responsive Transcription Factor of Eukaryotic Cells (A Review)
Schreck, R., Albermann, K., & Baeuerle, P. A. (1992) · Free Radical Research Communications · doi:10.3109/10715769209079515 · Cited by 1,388
The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1
Wang, W.-X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I., & Nelson, P. T. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5065-07.2008 · Cited by 701

Show all 41 references

Sorted by citations

Items 301–400 of 435

Determination of Potential Lead Compound from Magnolia officinalis for Alzheimer’s Disease through Pharmacokinetic Prediction, Molecular Docking, Dynamic Simulation, and Experimental Validation
Youn, K., & Jun, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910507 · Cited by 9
Unraveling the role of CGRP in neurological diseases: a comprehensive exploration to pathological mechanisms and therapeutic implications
Sarkar, S., Porel, P., Kosey, S., & Aran, K. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10542-y · Cited by 9
Multi-targeted approach via apigenin-7-O-glucoside for therapeutic intervention of Tau phosphorylating kinases in Alzheimer’s disease
Prabha, S., Choudhury, A., Jawaid, T., Saeed, M. U., Thakur, S. C., & Hassan, M. I. (2025) · 3 Biotech · doi:10.1007/s13205-025-04413-3 · Cited by 8
Does oxidatively damaged DNA drive amyloid-β generation in Alzheimer’s disease? A hypothesis
Sanders, O. D., Rajagopal, L., & Rajagopal, J. A. (2021) · Journal of Neurogenetics · doi:10.1080/01677063.2021.1954641 · Cited by 8
Toluidine blue O attenuates tau phosphorylation in N2a-APPSwe cells
Önder, S., Biberoğlu, K., Yuksel, M., & Tacal, Ö. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110126 · Cited by 8
Transcriptional activation of USP16 gene expression by NFκB signaling
Yang, S., Wang, J., Guo, S., Huang, D., Bestard‐Lorigados, I., Nie, X., Lou, D., Li, Y., Liu, M., Kang, Y. R., et al. (2019) · Molecular Brain · doi:10.1186/s13041-019-0535-3 · Cited by 8
Self-citation
Assessing the association between common functional Nuclear Factor Kappa-b gene polymorphisms (NFKB1, NFKBIZ, NFKBIA) and Alzheimer´s disease
Vázquez‐Coto, D., Pérez‐Oliveira, S., Menéndez‐González, M., Coto, E., & Álvarez, V. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115264 · Cited by 7
Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties
Pachón-Angona, I., Bernard, P. J., Simakov, A., Maj, M., Jóźwiak, K., Novotna, A., Lemke, C., Gütschow, M., Martin, H., Oset‐Gasque, M. J., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16010121 · Cited by 7
Dysregulated AEBP1 and COLEC12 Genes in Late-Onset Alzheimer’s Disease: Insights from Brain Cortex and Peripheral Blood Analysis
Asadie, M., Miri, A., Badri, T., Nejad, J. H., & Gharechahi, J. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02212-8 · Cited by 7
Investigation of Novel Aronia Bioactive Fraction-Alginic Acid Nanocomplex on the Enhanced Modulation of Neuroinflammation and Inhibition of Aβ Aggregation
Jang, B.-K., Shin, S. J., Park, H. H., Kumar, V., Park, Y., Kim, J. Y., Kang, H., Park, S. Y., Kwon, Y., Shin, S.-E., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics17010013 · Cited by 7
Reevaluating the role of amyloid β-peptides in Alzheimer’s disease: from pathogenic agents to protective chelation mechanisms
Cavaleri, F. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1550709 · Cited by 7
Glycogen synthase kinase 3β (GSK3β) and presenilin (PS) are key regulators of kinesin-1-mediated cargo motility within axons
Banerjee, R., & Gunawardena, S. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1202307 · Cited by 7
Controlled release of Clenbuterol from a hydroxyapatite carrier for the treatment of Alzheimer’s Disease
Lin, Y., Fang, C.-H., Liang, Y., Yang, C.-Y., Kuo, W., & Lin, F. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00432-4 · Cited by 7
Therapeutic Targets for the Treatment of Comorbidities Associated with Epilepsy
Gangar, K., & Bhatt, L. K. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666191203101606 · Cited by 7
Effects of Amyloid Precursor Protein Overexpression on NF-κB, Rho-GTPase and Pro-Apoptosis Bcl-2 Pathways in Neuronal Cells
Chan, H. H., Leong, Y. Q., Voon, S. M., Pan, M. L., Leong, C. O., Lim, C. L., & Koh, R. Y. (2021) · Reports of Biochemistry and Molecular Biology · doi:10.52547/rbmb.9.4.417 · Cited by 8
Multicomponent Reactions As a Privileged Tool for Multitarget-Directed Ligand Strategies in Alzheimer’s Disease Therapy
Grosjean, S., Pachón-Angona, I., Dawra, M., Refouvelet, B., & Ismaïli, L. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0170 · Cited by 7
Chitinase-3-Like Protein 1 as a Therapeutic Target for Inflammatory Diseases
Gu, S. M., Kim, T. H., Park, J. H., Lim, K., Jun, P. M., Lee, Y. S., Kweon, G. R., & Hong, J. T. (2025) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2025.050 · Cited by 6
Histone Deacetylase 2 in Alzheimer’s Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting
Asadi, K., Radha, K., Satarker, S., & Gurram, P. C. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05264-y · Cited by 7
PARP1 deficiency mitigates amyloid pathology, neurodegeneration, and cognitive decline in a familial Alzheimer’s disease model
Jhaldiyal, A., Kumari, M., Guttman, L. C., Tripathi, T., Khan, M. R., Wang, J., Biswas, D., Pasupuleti, A., Aggarwal, A., Pandya, S., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2525028123 · Cited by 6
Gamma-glutamyl transferase 5 overexpression in cerebrovascular endothelial cells improves brain pathology, cognition, and behavior in APP/PS1 mice
Zhang, Y., Li, T., Miao, J., Zhang, Z., Yang, M., Wang, Z., Yang, B., Zhang, J., Li, H., Su, Q., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01525 · Cited by 6
Protein arginine methyltransferases as regulators of cellular stress
Zaccarelli‐Magalhães, J., Citadin, C. T., Langman, J., Smith, D. J., Matuguma, L. H., Lin, H. W., & Udo, M. S. B. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115060 · Cited by 6
The neuroinflammatory role of microRNAs in Alzheimer’s disease: pathological insights to therapeutic potential
Liu, W., Rao, X., Sun, W., Chen, X., Yu, L., Zhang, J., Chen, J., & Zheng, X. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05164-0 · Cited by 6
Exploring the Diverse Roles of GSK-3β Kinase in Alzheimer’s Disease
Shareena, G., Kumar, D., & Thorat, N. D. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_11 · Cited by 7
IL-17A enhances the inflammatory response of glaucoma through Act1/TRAF6/NF-κB pathway
Zheng, Y., Mou, Z., Tan, S., Wang, X., Yuan, J., & Li, H. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105787 · Cited by 5
The prospective therapeutic benefits of sesamol: neuroprotection in neurological diseases
Guo, Y., Wang, Y., Xu, B., & Li, Y. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2457051 · Cited by 5
Blockage of CCL3 with neutralizing antibody reduces neuroinflammation and reverses Alzheimer disease phenotypes
Wei, C., Liu, J., Wu, B., Shen, T., Fan, J. J., Lin, Y., Li, L., Guo, Y., Shang, Y., Zhou, B., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.034 · Cited by 9
Effect of Exercise on Regulating miRNA Expression in Brain Health and Diseases
Zhang, J., Gu, F., & Thirupathi, A. (2025) · Biology · doi:10.3390/biology14060729 · Cited by 6
Astrocytic lipidopathy and bioenergetic failure in ApoE4-associated late-onset Alzheimer's disease: A unifying hypothesis
Garrahy, J. P. (2025) · Journal of Alzheimer’s Disease · doi:10.1177/13872877251350338 · Cited by 6
Bridging the molecular and clinical aspects of resveratrol in Alzheimer’s disease: a review
Mathew, L. S., Marathe, A., Aman, A., Vats, A., Joy, T., & Rao, Y. L. (2025) · 3 Biotech · doi:10.1007/s13205-025-04451-x · Cited by 5
Redox-Mediated Rewiring of Signalling Pathways: The Role of a Cellular Clock in Brain Health and Disease
Vujovic, F., Shepherd, C. E., Witting, P. K., Hunter, N., & Farahani, R. H. (2023) · Antioxidants · doi:10.3390/antiox12101873 · Cited by 5
Establishment of a novel cellular model for Alzheimer's disease in vitro studies
El-Araby, R. E., Wasif, K., Johnson, R., Tu, Q., Aboushousha, T., Zhu, Z. X., & Chen, J. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114820 · Cited by 5
Dopamine agonist Rotigotine mitigates lipopolysaccharide-induced neuroinflammation and memory impairment in mice
Gurram, P. C., Satarker, S., Nassar, A., Begum, F., Mudgal, J., Arora, D. S., & Nampoothiri, M. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01463-z · Cited by 5
Reduced SH3RF3 May Protect Against Alzheimer's Disease by Lowering Microglial Pro‐Inflammatory Responses via Modulation of JNK and NFkB Signaling
Patel, R., Cheng, R., Cardona, C. L., Angeles, E., Singh, G., Miller, S., Ashok, A., Teich, A. F., Piriz, A. L., Maldonado, A., et al. (2026) · Glia · doi:10.1002/glia.70165 · Cited by 5
Synthesis of New Hantzsch Adducts Showing Ca 2+ Channel Blockade capacity, Cholinesterase Inhibition and Antioxidant Power
Pachón-Angona, I., Maj, M., Wnorowski, A., Martin, H., Jóźwiak, K., & Ismaïli, L. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0176 · Cited by 5
Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD Network
Cao, S., Yu, L., Mao, J., Wang, Q., & Ruan, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144387 · Cited by 5
The many connections of UFMylation with Alzheimer’s disease: a comprehensive review
Yan, T., Clarkson, B. D. S., Lou, Z., Springer, W., & Fiesel, F. C. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00855-8 · Cited by 4
A novel multi-target compound mitigates amyloid plaques, synaptic deficits, and neuroinflammation in Alzheimer’s disease models
Lee, Y., Han, S., Lee, J., Cho, Y. E., Kim, J., Jeon, Y., Cho, H., Yoo, H., Byun, Y., Kim, T. K., et al. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01562-0 · Cited by 4
Natural Products from Chinese Medicine Targeting NF-κB Signaling: Emerging Therapeutic Avenues for Neurodegenerative Diseases
Wang, L., Feng, L., Ning, B., Wang, Z., Dai, C., & Li, M. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s534706 · Cited by 4
Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis
Chen, M., Ning, Y., Yang, H., & Jia, J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05500-5 · Cited by 4
Neural Correlates of Peripheral Inflammation in Major Depressive Disorder and Their Transcriptomic Architecture, Neurochemical Basis, and Behavioral Relevance
Zhao, W., Zhu, D., Zhang, Y., Zhang, Y., Shen, Y., Yu, Y., & Zhu, J. (2025) · Human Brain Mapping · doi:10.1002/hbm.70371 · Cited by 4
Contributing Factors of Neurodegeneration in Alzheimer’s Disease
Tailor, B. A., Pilozzi, A. R., & Huang, X. (2019) · Codon Publications eBooks · doi:10.15586/alzheimersdisease.2019.ch5 · Cited by 4
Discovery of New Highly Potent Histamine H3 Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors
Malek, R. S., Sałat, K., Totoson, P., Karcz, T. P., Refouvelet, B., Skrzypczak-Wiercioch, A., Maj, M., Simakov, A., Martin, H., Siwek, A., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00341 · Cited by 4
NF-κB signalling pathway in neurodegenerative diseases: Acupuncture as a potential therapeutic approach
Wang, Y., Zhou, Y., Tian, H., Li, Q., Chen, Y., Wang, L., Yin, Z., Zhou, J., & Liang, F. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149893 · Cited by 3
Can infliximab serve as a new therapy for neuropsychiatric symptoms?
Rahmati‐Dehkordi, F., Birang, N., Jalalian, M. N., Tamtaji, Z., Dadgostar, E., Aschner, M., Ardestani, M. S., Jafarpour, H., Mirzaei, H., Nabavizadeh, F., et al. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03397-w · Cited by 3
Exploring the Therapeutic Potential of Glycyrrhiza Compounds in Alzheimer's Disease: A Comprehensive Review
Song, X., Wang, X., Gao, Y., Xu, G., Yan, X., Chen, Z., & Song, G. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266322320240911194626 · Cited by 4
Chronic Airway Allergy Induces Pro-Inflammatory Responses in the Brain of Wildtype Mice but Not 3xTgAD Mice
Sarlus, H., Codita, A., Wang, X., Cedazo-Mı́nguez, Á., Schultzberg, M., & Oprica, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.005 · Cited by 3
CRISPR/Cas9-mediated knock-in cells of the late-onset Alzheimer’s disease-risk variant, SHARPIN G186R, reveal reduced NF-κB pathway and accelerated Aβ secretion
Asanomi, Y., Kimura, T., Shimoda, N., Shigemizu, D., Niida, S., & Ozaki, K. (2024) · Journal of Human Genetics · doi:10.1038/s10038-024-01224-x · Cited by 3
Signaling pathways in the treatment of Alzheimer’s disease with acupuncture: a narrative review
Ke, C., Shan, S., Tan, Y., Cao, Y., Xie, Z., Shi, S., Pan, J., & Zhang, W. (2024) · Acupuncture in Medicine · doi:10.1177/09645284241256669 · Cited by 3
The Mixture of Gastrodia elata and Glycyrrhiza uralensis Attenuates Scopolamine-Induced Cognitive Disorder
Lee, J., Kim, S. W., Lee, S.-H., Cho, J.-Y., Hwang, S.-H., Lee, W., Lee, J.-W., Kim, D., & Jeon, Y. (2023) · Applied Sciences · doi:10.3390/app13063690 · Cited by 3
Molecular Regulaion of BACE1 and Its Function at The Early Onset of Alzheimer′s Disease
Wang, T., & Sun, X. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00217 · Cited by 3
Chronic ghrelin administration suppresses IKK/NF-κB/BACE1 mediated Aβ production in primary neurons and improves cognitive function via upregulation of PP1 in STZ-diabetic rats
Ma, L., Liu, S., Du, J., Niu, Y., Hou, P.-F., Shu, Q., Ma, R., Wu, S., Qu, Q., & Lv, Y.-L. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.107155 · Cited by 3
Self-citation
Impaired 26S proteasome causes learning and memory deficiency and induces neuroinflammation mediated by NF-κB in micePreprint
Huber, C. C., Callegari, E. A., Paez, M., Li, X., Dwamena, A., & Wang, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.09.579699 · Cited by 3
GLP-1R agonists protect against Alzheimer’s disease by rewiring energy regulation
Na, D., & Schneeberger, M. (2025) · Nature Aging · doi:10.1038/s43587-025-00881-7 · Cited by 3
Alzheimer’s Disease-Related Proteins Targeted by Secondary Metabolite Compounds from Streptomyces: A Scoping Review
Zainuddin, M.-S., Bhuvanendran, S., Radhakrishnan, A. K., & Azman, A. S. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230065 · Cited by 2
Multi-Target Inhibitor of ZJQ- 3 F Against AChE/BACE1/GSK3β Targets Improves the Cognitive Impairment of APP/PS1/Tau Triple-Transgenic Mouse Models of Alzheimer’s Disease
Wang, N., Li, X., Jiang, X., Ning, X., Zhou, L., Liu, W., Wu, Q., Wang, X., Xing, Y., Qi, Z., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04982-7 · Cited by 2
Toxoplasma TgCtwh3 Δrop16Ⅰ/Ⅲ accelerates neuronal apoptosis and APP production in mouse with acute infection
Yang, D., Wang, C., Tao, Q., Liu, L., Jin, M., Cai, H., Zheng, M., Gong, M., Yu, L., Du, J., et al. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.009 · Cited by 2
Cognitive Resilience in Apolipoprotein ε4 Carrier Women Predicted by Neuron‐Derived Extracellular Vesicles
Manolopoulos, A., Mustapić, M., Nogueras‐Ortiz, C. J., Delgado‐Peraza, F., Pucha, K. A., Yao, P. J., Blommer, J. M., Vreones, M. P., York, W., Knight, D. L., et al. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70143 · Cited by 2
Pyranotacrines as prospective multi-target compounds against Alzheimer's disease
Fares, S., Husseiny, W. M. E., Selim, K. B., & Massoud, M. A. M. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118480 · Cited by 2
Computational Multi-target Drug Design
Guruprasad, L., Saxena, S., Banerjee, A., & Boggarapu, G. (2025) · Springer handbooks · doi:10.1007/978-3-031-81728-1_28 · Cited by 2
From Orange to Oncology: Anti-Inflammatory and Anti-Cancer Mechanisms of Sinensetin
Kim, D. J., Ahn, S., Xie, X., Seong, Y., & Yi, Y. W. (2026) · Cells · doi:10.3390/cells15020110 · Cited by 2
Lifestyle strategies and mechanistic implications for slowing neurodegeneration
Gunning, J., Hernandez, M. I., Gudarzi, B., Roushdy, H. M., Geda, Y. E., & Racette, S. B. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-026-00101-9 · Cited by 2
APP as an innate injury-response molecule
Olmsted, Z. T., & Sofroniew, M. V. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107361 · Cited by 3
The mechanism of actions of caffeine in Alzheimer’s disease: a systematic review of preclinical studies
Zhai, Y., Nevian, T., Finn, D. P., & Kwakowsky, A. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00025-0 · Cited by 2
HMGB1 signalling in Alzheimer’s disease: pathogenic roles and therapeutic prospects
Tyagi, P., Kumari, S., Sharma, P., Dhapola, R., Paidlewar, M., Medhi, B., & HariKrishnaReddy, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117204 · Cited by 2
The Impact of Ketogenic Diet Consumption on the Sporadic Alzheimer's Model Through MT1 / MT2 Regulation
Çimen, Y. A., Elibol, B., Korkmaz, N. D., Yüzgüleç, M., Kinsiz, B., Kutlu, S., & Üstünova, S. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70070 · Cited by 2
Propofol's effect on the sciatic nerve: Harmful or protective?
Sun, Y., Zhang, X., Zhou, Q., Wang, Y., Jiang, Y., & Cao, J. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.27.003 · Cited by 2
Heat Shock Proteins, a Key Modulator of Neuroinflammation in Alzheimer’s Disease
Panchal, K., Bhatt, V., Raval, M., & Tiwari, A. K. (2020) · Heat shock proteins · doi:10.1007/7515_2020_12 · Cited by 2
Therapeutic Potential of PPARs in Alzheimer’s Disease
Upaganlawar, A. B., Upasani, C. D., & Ihim, S. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_14 · Cited by 2
Neurodegeneration Associated with HIV-1 in the Era of cART
Ojeda-Juárez, D., Harahap-Carrillo, I. S., & Kaul, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_137 · Cited by 2
Emerging approaches for the treatment of Alzheimer disease: Targeting NF-κB pathwayPreprint
Goel, A. S., & Singh, S. (2020) · doi:10.22541/au.159493419.94920936 · Cited by 2
Curcumin Analogues as Novel Anti-Alzheimer's Candidates: Synthesis Development Strategy, In Vitro, Cell-Based and In Vivo Studies
Anas, Y., Susidarti, R. A., Yuniarti, N., & Martien, R. (2022) · INDONESIAN JOURNAL OF PHARMACY · doi:10.22146/ijp.4432 · Cited by 1
Investigating the therapeutic potential of 1,2,3,4,6 penta-O-galloyl-β-D-glucose in Alzheimer’s disease: a scoping review
Kahil, E. A., Jackson, A., D’Souza, B., Gorman, G. S., & Jumbo‐Lucioni, P. P. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2477226 · Cited by 1
Decoding Gene Regulation in Alzheimer’s Disease with Transfer Learning and Explainable Machine Learning
Peignier, S., Van, A. L., Meunier, Y., Pauliat, E., Zouari, M., & Calevro, F. (2025) · Lecture notes in computer science · doi:10.1007/978-3-032-01436-8_14 · Cited by 1
Rubiadin Alleviates Alzheimer’s Disease Pathology via NF-κB Pathway Regulation
Zhang, Y., Fan, J., Pan, J., Pan, J., Guo, W., & Zhang, Y. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin33497 · Cited by 1
Liraglutide improves cognitive function by reducing amyloid-beta peptide accumulation and inhibiting inflammation in 5 × FAD mice
Qi, L., Lin, L., Zheng, J., Liu, X., Liu, X., Chen, Z., & Liu, L. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf265 · Cited by 1
Glycogen synthase kinase-3 activation and dysregulation of amyloid transport receptors expression and shedding in HIV-induced Alzheimer’s disease-like pathology: modulatory effects of CCR5 antagonists
Bhargavan, B., Annadurai, N., & Kanmogne, G. D. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02197-4 · Cited by 1
Free radical-scavenging and anti-amyloidogenic properties of chicoric acid
He, M. T., Cho, E. J., Kim, J. H., & Kim, H. Y. (2025) · Applied Biological Chemistry · doi:10.1186/s13765-025-01047-0 · Cited by 1
Proposed unified model of late-onset Alzheimer's disease: Chronic astrocytic and neuronal bioenergetic failure
Garrahy, J. P. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251404970 · Cited by 1
Exploration of borneol essential oil function in the treatment of Alzheimer’s disease based on network pharmacology and experimental validation
You, C., Wu, S., Zhang, Y. E. L., Li, Q., Cui, Y., & Wu, Y. (2026) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-026-05280-y · Cited by 1
Female‐biased astrocytic priming shapes early locus coeruleus vulnerability in an Aβ oligomer milieu
Kushwaha, S., Choudhury, R. R., Bhat, P., Kumaran, S. S., & Karunakaran, S. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71168 · Cited by 1
FA-2-b-β modulates HMGB1/NF-κB/NLRP3 signaling to alleviate neuroinflammation in Alzheimer’s disease
Zhang, Y., Wang, J., Yuan, J., Li, S., & Sun, Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261418300 · Cited by 1
Sovateltide at the heart–brain axis crosstalk in Alzheimer’s disease: a promising multi-target and cutting-edge therapeutic approach
Kushawaha, S. K., Vashisht, K., Kumar, H., Ankalgi, A. D., Ashawat, M. S., & Baldi, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02215-4 · Cited by 1
Peripheral biomarkers of neuroinflammation in Alzheimer’s disease and vascular dementia
Ouyang, X., Chia, R. S. L., Chai, Y. L., Chong, Sim, M. A., Jo, D., Arumugam, T. V., Sethi, G., Dawe, G. S., Chen, C. P., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118077 · Cited by 1
Self-citation
Chicken meat protein hydrolysate as a functional food ingredient: Antioxidant and dual-targeting neuroprotection against Alzheimer's disease via anti-amyloidogenic and anti-inflammatory pathways
Sangsawad, P., Yongsawatdigul, J., Panlamjeak, S., Laosam, P., Rouabhia, M., & Promyo, K. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107393 · Cited by 1
Redefining CHI3L1: Therapeutic Opportunities at the Crossroads of Immune Suppression and Disease Progression
Upmanyu, K., Upadhyay, S., & Gabr, M. T. (2026) · Medicinal Research Reviews · doi:10.1002/med.70076 · Cited by 1
NF-κB across the Alzheimer disease spectrum: Context-dependent protective and pathogenic roles
Azargoonjahromi, A., Abutalebian, F., & Nasiri, H. (2026) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2026.08.008 · Cited by 1
Frontiers in Clinical Drug Research - Alzheimer Disorders
Atta-ur-rahman, Mavoungou, C., Zimmerman, K. S., Wright, J., Harding, J., Cavallaro, R., Fuso, A., Yoshiyama, Y., Asija, Z., Clifford, A., et al. (2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97816810806801150301 · Cited by 1
In Silico Evaluation of Marine Phytochemicals as Potential Inhibitors of Inhibitor-Kappa B Protein Kinase (IκK) for Alzheimer’s Disease Therapeutics
Sheokand, D., Grewal, A., Kumar, V., Chauhan, R., Saini, V., & Kumar, A. (2024) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3286 · Cited by 1
Phikud navakot extract acts as an ER stress inhibitor to ameliorate ER stress and neuroinflammation
Temviriyanukul, P., Chansawhang, A., Inthachat, W., Supasawat, P., Phochantachinda, S., Pitchakarn, P., & Chantong, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39700 · Cited by 1
Atypical Protein Kinase C Hyperactivity in Insulin-Resistant and Insulin-Sensitive Forms of Alzheimer’s Disease: A Potential Therapeutic Target
Farese, R. V., Kindy, M. S., & Sajan, M. P. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch6 · Cited by 1
Neurodegeneration Associated with HIV-1 in the Era of cART
Ojeda-Juárez, D., Harahap-Carrillo, I. S., & Kaul, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_137-1 · Cited by 1
Microglia and border-associated macrophages in the central nervous system
Zanluqui, N. G., Polonio, C. M., de Oliveira, M. G., de Oliveira, L. G., Faria, L. C., & Peron, J. P. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821385-8.00013-5 · Cited by 1
Inhibition of secretase: A promising technique for Alzheimer’s disease patients
Mukherjee, P., Saha, A., Sanyal, T., & Sen, K. (2023) · International Journal of Advanced Research Trends in Science. · doi:10.70035/ijarts.2023.2131-35 · Cited by 1
Evaluation of BACE1 silencing as a therapy against Alzheimer disease: implications for lipid metabolism and inflammatory response
Villamil-Ortiz, J. G. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.99684546 · Cited by 1
Deep interpretable learning of sample representations for characterizing disease states in single-cell transcriptomicsPreprint
Wagle, M. M., Wang, Y., Samanta, S., Liu, Z., Patrick, E., Yang, P., & Kellis, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.21.738207 · Cited by 1
Nitric Oxide Donors in Brain Inflammation
Godínez-Rubí, M., & Ortuño‐Sahagún, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809275-0.00011-9
BACE1 is a novel regulator of Th17 function in EAE
Hernández-Mir, G. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Microangiopathie cérébrale et démence : de la physiopathologie aux perspectives thérapeutiques
Albaret, G., & Debette, S. (2018) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2018.02.003 · Cited by 1
CSF TNF-α Levels Were Associated with Longitudinal Change in Brain Glucose Metabolism Among Non-Demented Older People
Fu, P., Zhu, B., & Huang, Y. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s291020
Elucidating the mechanisms of lipopolysaccharide-induced cognitive impairment in rats treated with tualang honey and its methanolic extraction
Yaacob, W. M. H. W. (2020) · Universiti Sains Malaysia Institutional Repository (Universiti Sains Malaysia)

Authors: Chen, C.-H., Zhou, W., Liu, S., Deng, Y., Cai, F., Tone, M., Tone, Y., Tong, Y., & Song, W.
Affiliations: University of British Columbia (CA)
University of Pennsylvania (US)
Corresponding author: Song, Weihong
ORCID: Zhou, Weihui
Liu, Shengchun
Deng, Yu
Cai, Fang
Tong, Yigang
Song, Weihong
Venue: The International Journal of Neuropsychopharmacology
Publisher: Oxford University Press (OUP)
Published: 2011-02-18
Volume: 15
Issue: 01
Pages: 77-90
ISSN: 1461-1457 (ISSN-L)
1469-5111
DOI: 10.1017/s1461145711000149
OpenAlex: W2158215064
Cited by: 433
References: 41
Citations by year: 2026: 33 · 2025: 55 · 2024: 51 · 2023: 39 · 2022: 40 · 2021: 26 · 2020: 47 · 2019: 25 · 2018: 25 · 2017: 18 · 2016: 20 · 2015: 17 · 2014: 12 · 2013: 11 · 2012: 6
FWCI: 7.85
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The International Journal of Neuropsychopharmacology (publishedVersion)
PubMed (publishedVersion)
Funders: Michael Smith Health Research BC
Canada Research Chairs
Canadian Institutes of Health Research
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, BACE1, NF-κB signaling, NF-κB p65, beta-secretase, amyloid-beta production, APP processing, transcriptional regulation, nonsteroidal anti-inflammatory drugs, TNF-α, inflammation, therapeutic target
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Anti-Inflammatory Agents, Non-Steroidal, Brain, Humans, Promoter Regions, Genetic, Transcription, Genetic, Tumor Necrosis Factor-alpha, Signal Transduction, Up-Regulation, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Transcription Factor RelA, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks